Therapeutic Area | MeSH |
---|---|
infections | D007239 |
respiratory tract diseases | D012140 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
XENLETA | Hong Kong King-Friend Industrial Company | N-211672 RX | 2019-08-19 | 1 products, RLD, RS |
XENLETA | Hong Kong King-Friend Industrial Company | N-211673 RX | 2019-08-19 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
citric buffered normal saline xenleta | New Drug Application | 2024-10-11 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
bacterial pneumonia | EFO_1001272 | D018410 | J15.9 |
Expiration | Code | ||
---|---|---|---|
LEFAMULIN ACETATE, XENLETA, NABRIVA | |||
2029-08-19 | GAIN | ||
2024-08-19 | NCE |
Code | Description |
---|---|
J0691 | Injection, lefamulin, 1 mg |
Drug common name | Lefamulin |
INN | lefamulin |
Description | Lefamulin, sold under the brand name Xenleta, is an antibiotic medication used it to treat adults with community-acquired bacterial pneumonia. It is taken by mouth or by injection into a vein.
|
Classification | Small molecule |
Drug class | antibacterials, pleuromulin derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C=C[C@]1(C)C[C@@H](OC(=O)CS[C@@H]2CC[C@@H](N)C[C@H]2O)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O |
PDB | — |
CAS-ID | 1061337-51-6 |
RxCUI | — |
ChEMBL ID | CHEMBL3291398 |
ChEBI ID | — |
PubChem CID | 25185057 |
DrugBank | DB12825 |
UNII ID | 21904A5386 (ChemIDplus, GSRS) |